ADAM BLANTON: Open Payments
NPI 1508258856 · WILLIAMSON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 21 payments from 8 companies in 2025. Trend: 2023 $107 · 2024 $237 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $146 |
| GlaxoSmithKline, LLC. | 5 | $110 |
| Boston Scientific Corporation | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Braeburn Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: TRELEGY ELLIPTA, QULIPTA, VRAYLAR, UBRELVY, WATCHMAN Access System, JOURNAVX, CAPLYTA, NURTEC ODT.
Industry payments across WV — which companies pay providers there.
